239 related articles for article (PubMed ID: 33293807)
1. Anticancer Activity of Thymoquinone Cubic Phase Nanoparticles Against Human Breast Cancer: Formulation, Cytotoxicity and Subcellular Localization.
Mehanna MM; Sarieddine R; Alwattar JK; Chouaib R; Gali-Muhtasib H
Int J Nanomedicine; 2020; 15():9557-9570. PubMed ID: 33293807
[TBL] [Abstract][Full Text] [Related]
2. Mechanistic Study on Thymoquinone Conjugated ZnO Nanoparticles Mediated Cytotoxicity and Anticancer Activity in Triple-Negative Breast Cancer Cells.
Banupriya SK; Kavithaa K; Poornima A; Sumathi S
Anticancer Agents Med Chem; 2022; 22(2):313-327. PubMed ID: 33845751
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and Characterization of PLGA-PEG Thymoquinone Nanoparticles and Its Cytotoxicity Effects in Tamoxifen-Resistant Breast Cancer Cells.
Ahmad R; Kaus NHM; Hamid S
Adv Exp Med Biol; 2020; 1292():65-82. PubMed ID: 30560443
[TBL] [Abstract][Full Text] [Related]
4. Formulation, Characterization and Cytotoxicity Effects of Novel Thymoquinone-PLGA-PF68 Nanoparticles.
Noor NS; Kaus NHM; Szewczuk MR; Hamid SBS
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502328
[TBL] [Abstract][Full Text] [Related]
5. Thymoquinone-loaded nanostructured lipid carrier exhibited cytotoxicity towards breast cancer cell lines (MDA-MB-231 and MCF-7) and cervical cancer cell lines (HeLa and SiHa).
Ng WK; Saiful Yazan L; Yap LH; Wan Nor Hafiza WA; How CW; Abdullah R
Biomed Res Int; 2015; 2015():263131. PubMed ID: 25632388
[TBL] [Abstract][Full Text] [Related]
6. PEGylated-thymoquinone-nanoparticle mediated retardation of breast cancer cell migration by deregulation of cytoskeletal actin polymerization through miR-34a.
Bhattacharya S; Ahir M; Patra P; Mukherjee S; Ghosh S; Mazumdar M; Chattopadhyay S; Das T; Chattopadhyay D; Adhikary A
Biomaterials; 2015 May; 51():91-107. PubMed ID: 25771001
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of Carum-loaded Niosomes on Breast Cancer Cells:Physicochemical Properties, In Vitro Cytotoxicity, Flow Cytometric, DNA Fragmentation and Cell Migration Assay.
Barani M; Mirzaei M; Torkzadeh-Mahani M; Adeli-Sardou M
Sci Rep; 2019 May; 9(1):7139. PubMed ID: 31073144
[TBL] [Abstract][Full Text] [Related]
8. Thymoquinone in liposomes: a study of loading efficiency and biological activity towards breast cancer.
Odeh F; Ismail SI; Abu-Dahab R; Mahmoud IS; Al Bawab A
Drug Deliv; 2012 Nov; 19(8):371-7. PubMed ID: 23043626
[TBL] [Abstract][Full Text] [Related]
9. Lipidic cubic-phase leflunomide nanoparticles (cubosomes) as a potential tool for breast cancer management.
Zewail M; E Gaafar PM; Ali MM; Abbas H
Drug Deliv; 2022 Dec; 29(1):1663-1674. PubMed ID: 35616281
[TBL] [Abstract][Full Text] [Related]
10. Molecular targeting of Akt by thymoquinone promotes G(1) arrest through translation inhibition of cyclin D1 and induces apoptosis in breast cancer cells.
Rajput S; Kumar BN; Dey KK; Pal I; Parekh A; Mandal M
Life Sci; 2013 Nov; 93(21):783-90. PubMed ID: 24044882
[TBL] [Abstract][Full Text] [Related]
11. Thymoquinone as an anticancer agent: evidence from inhibition of cancer cells viability and invasion in vitro and tumor growth in vivo.
Attoub S; Sperandio O; Raza H; Arafat K; Al-Salam S; Al Sultan MA; Al Safi M; Takahashi T; Adem A
Fundam Clin Pharmacol; 2013 Oct; 27(5):557-69. PubMed ID: 22788741
[TBL] [Abstract][Full Text] [Related]
12. Formulation, Cellular Uptake and Cytotoxicity of Thymoquinone-Loaded PLGA Nanoparticles in Malignant Melanoma Cancer Cells.
Ibrahim WN; Muizzuddin Bin Mohd Rosli L; Doolaanea AA
Int J Nanomedicine; 2020; 15():8059-8074. PubMed ID: 33116518
[TBL] [Abstract][Full Text] [Related]
13. Thymoquinone loaded mesoporous silica nanoparticles retard cell invasion and enhance in vitro cytotoxicity due to ROS mediated apoptosis in HeLa and MCF-7 cell lines.
Goel S; Mishra P
Mater Sci Eng C Mater Biol Appl; 2019 Nov; 104():109881. PubMed ID: 31499940
[TBL] [Abstract][Full Text] [Related]
14. Thymoquinone Inhibits Proliferation and Migration of MDA-MB-231 Triple Negative Breast Cancer Cells by Suppressing Autophagy, Beclin-1 and LC3.
Ünal TD; Hamurcu Z; Delibaşı N; Çınar V; Güler A; Gökçe S; Nurdinov N; Ozpolat B
Anticancer Agents Med Chem; 2021; 21(3):355-364. PubMed ID: 32767958
[TBL] [Abstract][Full Text] [Related]
15. Delivery of phytochemical thymoquinone using molecular micelle modified poly(D, L lactide-co-glycolide) (PLGA) nanoparticles.
Ganea GM; Fakayode SO; Losso JN; van Nostrum CF; Sabliov CM; Warner IM
Nanotechnology; 2010 Jul; 21(28):285104. PubMed ID: 20585163
[TBL] [Abstract][Full Text] [Related]
16. Development of curcumin-loaded gemini surfactant nanoparticles: Synthesis, characterization and evaluation of anticancer activity against human breast cancer cell lines.
Karimpour M; Feizi MAH; Mahdavi M; Krammer B; Verwanger T; Najafi F; Babaei E
Phytomedicine; 2019 Apr; 57():183-190. PubMed ID: 30776589
[TBL] [Abstract][Full Text] [Related]
17. AT101-Loaded Cubosomes as an Alternative for Improved Glioblastoma Therapy.
Flak DK; Adamski V; Nowaczyk G; Szutkowski K; Synowitz M; Jurga S; Held-Feindt J
Int J Nanomedicine; 2020; 15():7415-7431. PubMed ID: 33116479
[TBL] [Abstract][Full Text] [Related]
18. Targeted anticancer potential against glioma cells of thymoquinone delivered by mesoporous silica core-shell nanoformulations with pH-dependent release.
Shahein SA; Aboul-Enein AM; Higazy IM; Abou-Elella F; Lojkowski W; Ahmed ER; Mousa SA; AbouAitah K
Int J Nanomedicine; 2019; 14():5503-5526. PubMed ID: 31410001
[TBL] [Abstract][Full Text] [Related]
19. Development and biological evaluation of protective effect of kidney targeted N-acetylated chitosan nanoparticles containing thymoquinone for the treatment of DNA damage in cyclophosphamide-induced haemorrhagic cystitis.
Prajapati C; Agrawal YO; Agnihotri VV; Mahajan UB; Patil KR; Patil DD; Patil CR
Int J Biol Macromol; 2022 Aug; 214():391-401. PubMed ID: 35714868
[TBL] [Abstract][Full Text] [Related]
20. Incorporation of docetaxel and thymoquinone in borage nanoemulsion potentiates their antineoplastic activity in breast cancer cells.
Alkhatib MH; Bawadud RS; Gashlan HM
Sci Rep; 2020 Oct; 10(1):18124. PubMed ID: 33093596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
